ISRG vs ROK: How Intuitive Surgical and Rockwell Automation Compare (2026)
Short answer
ISRG (Intuitive Surgical) and ROK (Rockwell Automation) are often compared because they share investment themes, but they are different businesses. Intuitive Surgical (ISRG) is the dominant maker of robotic-assisted surgery systems, best known for the da Vinci platform used in minimally invasive procedures across urology, gynecology, general surgery, and other specialties. Rockwell Automation (ROK) is one of the largest pure-play industrial automation and digital transformation companies in the world. Neither is universally better: pick by which thesis you are expressing and what you already own. This is descriptive, not a recommendation.
What does Intuitive Surgical (ISRG) do?
Intuitive Surgical (ISRG) is the dominant maker of robotic-assisted surgery systems, best known for the da Vinci platform used in minimally invasive procedures across urology, gynecology, general surgery, and other specialties. Its business model is razor-and-blade: Intuitive sells or places the large capital systems, then earns high-margin recurring revenue from the single-use instruments and accessories consumed in each procedure, plus service contracts. As the installed base of systems grows and procedure volumes rise, recurring revenue compounds. The company has expanded its platform with newer systems (including the da Vinci 5 and the Ion platform for lung biopsy), and benefits from surgeon training, hospital workflow integration, and a large library of validated procedures that create high switching costs. Intuitive went public in 2000 and is headquartered in Sunnyvale, California. It is the clear leader in surgical robotics with a wide moat, strong margins, and consistent procedure-volume growth, though it trades at a premium valuation that reflects those qualities.
What does Rockwell Automation (ROK) do?
Rockwell Automation (ROK) is one of the largest pure-play industrial automation and digital transformation companies in the world. It provides the hardware, software, and services that factories and industrial facilities use to run, monitor, and optimize their operations: programmable logic controllers, drives, motor control, sensors, industrial networking, and the Allen-Bradley and FactoryTalk product families that are standards in many North American plants. Rockwell organizes its business around Intelligent Devices, Software and Control, and Lifecycle Services, and increasingly pairs its installed base of automation hardware with software, analytics, and recurring services. A long partnership with software firms and its acquisitions in areas like manufacturing-execution software, cybersecurity, and information solutions position it to sell connected, data-driven factory systems, not just discrete controllers. Founded in 1903 and headquartered in Milwaukee, Wisconsin, Rockwell is an S&P 500 industrial that benefits from secular trends in reshoring, factory modernization, and the digitization of manufacturing, while remaining tied to the capital-spending cycles of its industrial customers.
ISRG vs ROK: how do they differ?
Both fit overlapping themes, but they are not interchangeable. Intuitive Surgical is best understood through its own drivers, and Rockwell Automation through its. The useful comparison is which set of drivers and risks you want exposure to.
- ISRG drivers: Razor-and-blade recurring revenue; Installed base and switching costs.
- ROK drivers: Installed base and switching costs; Software, recurring revenue, and analytics.
ISRG vs ROK: how they make money and what they cost
ISRG. Intuitive trades at a high earnings multiple that reflects its dominant market position, high-margin recurring revenue, strong balance sheet, and consistent procedure-volume growth. The premium is the central debate: bulls justify it with the durability of the razor-and-blade model and a long runway, while bears point to multiple-compression risk if procedure growth slows or competitors gain share. Figures are approximate and should be verified against the latest filing.
ROK. Rockwell typically trades at a premium multiple relative to the broader industrials group, reflecting its pure-play automation focus, strong installed-base moat, and growing software mix. The valuation embeds expectations for factory modernization and reshoring; multiple compression risk rises if the industrial capital-spending cycle weakens or order growth disappoints. Figures are approximate and move with results and price; verify current revenue, margins, and yield.
Headline figures (approximate, early 2026): ISRG shows revenue (ttm) ~$8 to 9 billion (verify), recurring revenue share ~80%+ from instruments, accessories, and service, operating margin ~30% (strong); ROK shows revenue (ttm) ~$8 billion (verify), operating margin ~ high teens to ~20% segment margins (verify), profitability Consistently profitable. A cheaper-looking multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is actually compounding.
Which fits which kind of investor
Both share a theme, but they suit different temperaments. Intuitive Surgical's case leans on razor-and-blade recurring revenue, and Rockwell Automation's on installed base and switching costs. A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: ISRG trades at a premium valuation, so any slowdown in procedure growth, system placements, or margins can compress the multiple sharply. For ROK, rockwell's results are tied to industrial and manufacturing capital-spending cycles, so demand can soften in downturns or when customers delay projects, and orders can be lumpy.
ISRG or ROK: which should you pick?
The bottom line: ISRG vs ROK
ISRG and ROK are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ISRG and ROK exposure against your real portfolio. It is not an investment adviser.
Build a basket around ISRG with Walnut
Use Intuitive Surgical as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
What is the difference between ISRG and ROK?
+
Intuitive Surgical (ISRG) is the dominant maker of robotic-assisted surgery systems, best known for the da Vinci platform used in minimally invasive procedures across urology, gynecology, general surgery, and other specialties. Rockwell Automation (ROK) is one of the largest pure-play industrial automation and digital transformation companies in the world. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is ISRG or ROK the better stock?
+
Walnut is informational, not investment advice. Neither is universally better; ISRG and ROK suit different views and risk levels. Compare what each does, how they make money, and the risks, then decide which fits your thesis and what you already own.
Should you own both ISRG and ROK?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both before you add the second.
What are the risks of ISRG vs ROK?
+
ISRG: ISRG trades at a premium valuation, so any slowdown in procedure growth, system placements, or margins can compress the multiple sharply. Competition is intensifying as Medtronic, Johnson & Johnson, and others develop rival surgical-robotics platforms that could erode Intuitive's dominance over time. Hospital capital budgets are cyclical and can defer system purchases in tight economic periods. Reimbursement changes, regulatory scrutiny of new systems, and any safety or recall issues are risks. The company is also exposed to global healthcare-spending trends and currency, and the high valuation leaves little room for execution missteps. ROK: Rockwell's results are tied to industrial and manufacturing capital-spending cycles, so demand can soften in downturns or when customers delay projects, and orders can be lumpy. It competes with large global automation rivals like Siemens, Schneider Electric, ABB, and Emerson, several of which have broader geographic and product breadth. Exposure to specific end markets (autos, semiconductors, food and beverage, energy) introduces concentration and cyclicality. Supply-chain disruptions and component availability have affected lead times in the past. The stock often trades at a premium multiple for an industrial, so disappointing orders or margins can pressure the valuation.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell ISRG or ROK; figures are approximate and dated. Verify current data before investing.